TKIs for Advanced HCC in the Second Line and Beyond
CCO Oncology Podcast - Podcast autorstwa Clinical Care Options
Kategorie:
In this podcast episode, experts Josep M. Llovet, MD, PhD, and Univ. Prof. Markus Peck-Radosavljevic, MD, MBA, discuss the role of tyrosine kinase inhibitors in treating patients with advanced HCC in the second line and beyond.
